$MGROF Provides Update on Biopesticide Pipeline

MustGrow (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) is an innovative agriculture biotech company focused on providing natural biological protection for high value crops and other markets. Recently the company provided an update of its biopesticide product pipeline. The company — by extracting natural compounds from within the mustard seed — the mustard plant’s natural defense mechanism — has provided natural solutions to potentially replace widely used harmful synthetics that are being deregistered and banned. A recent article discussing this reads, “As part of the update, the company reported that a U.S. EPA registration already exists for its biopesticide product in granule format for use as a preplant soil treatment for high-value crops such as fruits and vegetables. The company is now working to obtain a new registration for its biopesticide in liquid format. As with the granular biopesticide, the liquid format is also made from food-grade mustard and has the same active ingredient: AITC. The new liquid biopesticide will be called TerraMG, and MustGrow is anticipating EPA approvals this year.”

To view the full article, visit: https://ibn.fm/tTmou

About MustGrow Biologics Corp.

MustGrow is a publicly traded agriculture biotech company focused on providing natural science-based biological solutions for high value crops, including fruits and vegetables. MustGrow has designed and owns a United States EPA-approved natural solution that uses the mustard seed’s natural defense mechanism to protect plants from pests and diseases. Over 110 independent tests have been completed, validating MustGrow’s safe and effective signature products. The product, in granule format, is EPA-approved across all key U.S. states and by Health Canada’s PMRA (Pest Management Regulatory Agency) as a bio-pesticide for high value crops such as in fruit and vegetables. MustGrow has now concentrated a liquid format, TerraMG, which, with regulatory approval, could be applied through standard drip or spray equipment, improving functionality and performance features. For more information, visit the company’s website at www.MustGrow.ca.

NOTE TO INVESTORS: The latest news and updates relating to MGROF are available in the company’s newsroom at http://ibn.fm/MGROF

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.